These results highlight the implication of BTN3A1 for inflammation and SLE development, and suggest a novel mechanism by which BTN3A1 is involved in ferroptosis of CD4+ T cells through inhibition of IL‐38. The gene discussed is BTN3A1; the disease is systemic lupus erythematosus.